Siga Technologies (SIGA) EPS (Weighted Average and Diluted) (2010 - 2025)
Siga Technologies (SIGA) reported EPS (Weighted Average and Diluted) of -$0.09 for Q3 2025, down 550.0% on a YoY basis from $0.02 in Q3 2024, and down 118.37% quarter-over-quarter from $0.49 in Q2 2025.
Siga Technologies (SIGA) EPS (Weighted Average and Diluted) (2010 - 2025) Analysis & Trends
Siga Technologies has reported EPS (Weighted Average and Diluted) for 16 years, with the latest figure at -$0.09 in Q3 2025.
- For the quarter ending Q3 2025, EPS (Weighted Average and Diluted) fell 550.0% year-over-year to -$0.09; the trailing twelve-month figure through Sep 2025 stood at $1.02 (down 15.0% YoY), and the FY2024 full-year result was $0.82, down 13.68% from the prior year.
- EPS (Weighted Average and Diluted) for Q3 2025 stood at -$0.09, down from $0.49 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was $1.01 in Q4 2023, with the low at -$0.09 in Q3 2025.
- Historically, EPS (Weighted Average and Diluted) has averaged $0.19 across 5 years, with a median of -$0.0 in 2021.
- Annual changes were most pronounced in 2023 — EPS (Weighted Average and Diluted) surged 10200.0% — and 2025, when it plunged 550.0%.
- Siga Technologies' EPS (Weighted Average and Diluted) stood at $0.96 in 2021, then slumped by 101.04% to -$0.01 in 2022, then soared by 10200.0% to $1.01 in 2023, then slumped by 37.62% to $0.63 in 2024, then slumped by 114.29% to -$0.09 in 2025.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.09 (Q3 2025), $0.49 (Q2 2025), and -$0.01 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 0.31 |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 1.42 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 5.82 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 0.02 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.91 |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 0.11 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -0.40 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.80 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -0.40 |
| 10 | Siga Technologies | 310.79 Mn | 155.83 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -0.09 |
| Jun 30, 2025 | 0.49 |
| Mar 31, 2025 | -0.01 |
| Dec 31, 2024 | 0.63 |
| Sep 30, 2024 | 0.02 |
| Jun 30, 2024 | 0.03 |
| Mar 31, 2024 | 0.14 |
| Dec 31, 2023 | 1.01 |
| Sep 30, 2023 | -0.01 |
| Jun 30, 2023 | -0.04 |
| Mar 31, 2023 | -0.01 |
| Dec 31, 2022 | -0.01 |
| Sep 30, 2022 | 0.45 |
| Jun 30, 2022 | 0.03 |
| Mar 31, 2022 | -0.01 |
| Dec 31, 2021 | 0.96 |
| Sep 30, 2021 | -0.04 |
| Jun 30, 2021 | 0.00 |
| Mar 31, 2021 | -0.02 |
| Dec 31, 2020 | 0.26 |